Mice Models Industry Strategic Market Roadmap: Analysis and Forecasts 2025-2033

Key Insights

The global mice models market, valued at $1.5 billion in 2025, is projected to experience robust growth, driven by the increasing demand for preclinical research in drug discovery and development. This growth is fueled by several key factors. Firstly, the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders necessitates extensive preclinical testing, making mice models indispensable. Secondly, advancements in genetic engineering technologies, particularly CRISPR/Cas9, are enabling the creation of highly specific and accurate mouse models, mirroring human diseases with greater fidelity. This leads to more reliable and translatable research outcomes. Finally, the growing outsourcing of research activities to contract research organizations (CROs) and the increasing adoption of sophisticated breeding and cryopreservation techniques further contribute to market expansion. The market is segmented by type (Inbred, Outbred, Genetically Engineered, Hybrid/Congenic, Other), service (Breeding, Cryopreservation, Model in-Licensing, Genetic Testing, Other), technology (CRISPR/CAS, Embryonic Stem Cell Injection, Nuclear Transfer, Other), and application (Oncology, Cardiovascular Studies, Neurology, Other). North America currently holds a significant market share due to the presence of major research institutions and CROs. However, Asia Pacific is expected to witness rapid growth due to increasing investments in life sciences research and development in countries like China and India.

The market's CAGR of 6.80% from 2025 to 2033 signifies a consistently expanding market. While restraints may include ethical considerations surrounding animal research and regulatory hurdles, the overall positive market trajectory is firmly established by the undeniable need for effective preclinical models in advancing biomedical research. Competition among key players like Charles River Laboratories, Taconic Biosciences, and Jackson Laboratory is intensifying, driving innovation and the development of more sophisticated and cost-effective mice models. Future growth will likely be influenced by ongoing technological advancements, expanding therapeutic areas, and government regulations related to animal welfare and research ethics. The market's expansion will necessitate a continuous refinement of ethical guidelines and efficient resource allocation to sustain the responsible development and utilization of mice models.

Mice Models Industry Market Report: 2019-2033

This comprehensive report provides a detailed analysis of the Mice Models industry, encompassing market dynamics, growth trends, regional segmentation, product landscape, key players, and future outlook. The study period spans from 2019 to 2033, with 2025 serving as the base and estimated year. The report leverages extensive market research and data analysis to deliver actionable insights for industry professionals. The market is segmented by type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Other Types), service (Breeding, Cryopreservation, Model in-Licensing, Genetic Testing, Other Services), technology (CRISPR/CAS, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies), and application (Oncology, Cardiovascular Studies, Neurology, Other Applications). Key players analyzed include Ozgene Pty Ltd, The Jackson Laboratory, Janvier Labs, The Andersons Inc, Trans Genic Inc, Ingenious Targeting Laboratory, ENVIGO, Charles River Laboratories International Inc, Taconic Biosciences Inc, Genoway, Horizon Discovery Group PLC (Sage Labs Inc), Allentown LLC, Harbour Biomed, and PolyGene.

Mice Models Industry Market Dynamics & Structure

The global mice models market is characterized by a moderately concentrated landscape, with a few large players holding significant market share. Technological innovation, primarily driven by advancements in gene editing technologies like CRISPR/Cas9, is a key growth driver. Stringent regulatory frameworks governing animal research influence market operations, while the availability of alternative research methods presents competitive substitution pressures. The market exhibits substantial end-user diversity, spanning academic research institutions, pharmaceutical companies, and biotechnology firms. M&A activity in the sector remains moderate, with a focus on expanding service offerings and geographical reach. In 2024, approximately xx M&A deals were recorded, resulting in a xx% increase in market concentration.

• Market Concentration: Moderately concentrated, with top 5 players holding approximately 60% market share in 2025.
• Technological Innovation: CRISPR/Cas9, embryonic stem cell injection, and nuclear transfer are key technological drivers.
• Regulatory Framework: Stringent regulations regarding animal welfare and research ethics impact market dynamics.
• Competitive Substitutes: Alternative research methods, such as in silico modeling, pose competitive pressure.
• End-User Demographics: Primarily academic institutions (45%), pharmaceutical companies (35%), and biotech firms (20%).
• M&A Trends: Moderate activity, driven by expansion strategies and service diversification.

Mice Models Industry Growth Trends & Insights

The global mice models market witnessed significant growth during the historical period (2019-2024), expanding from $xx million in 2019 to $xx million in 2024, exhibiting a CAGR of xx%. This growth is attributed to increasing research and development activities in the pharmaceutical and biotechnology sectors, coupled with the rising adoption of genetically engineered mouse models for disease research. Technological advancements in gene editing and other related technologies have further accelerated market growth. The market penetration rate for genetically engineered mice models is expected to increase from xx% in 2025 to xx% by 2033. Consumer behavior shifts towards more precise and efficient research models are driving the demand for advanced mice models, including those with specific genetic modifications. The forecast period (2025-2033) projects continued expansion, with a projected market value of $xx million by 2033 and a CAGR of xx%.

Dominant Regions, Countries, or Segments in Mice Models Industry

North America currently dominates the mice models market, driven by extensive research infrastructure, substantial funding for biomedical research, and the presence of major players in the industry. Within North America, the United States holds the largest market share. Europe follows as a significant market, fueled by increasing investments in life sciences research. Genetically Engineered Mice represents the fastest-growing segment, driven by increasing demand for disease modeling and drug discovery research. Breeding services account for the largest share of the services segment.

• Key Drivers:
  • North America: Strong research infrastructure, significant R&D funding.
  • Europe: Growing investments in life sciences, expanding pharmaceutical sector.
  • Asia-Pacific: Emerging economies, rising healthcare spending.
• Dominant Segments:
  • Genetically Engineered Mice: High demand for disease modeling and drug discovery.
  • Breeding Services: Largest share within the services segment.

Mice Models Industry Product Landscape

The mice models market offers a diverse range of products, including inbred, outbred, and genetically engineered mice, catering to various research needs. Recent innovations have focused on enhancing the fidelity and accuracy of models, incorporating humanized immune systems or specific genetic mutations relevant to target diseases. The CRISPR/Cas9 technology plays a significant role in developing customized mouse models, enabling precise gene editing and generation of novel models. Key performance metrics include reproducibility, phenotype consistency, and disease modeling accuracy. The unique selling proposition of many products lies in their ability to provide highly specific and reliable models for complex human diseases.

Key Drivers, Barriers & Challenges in Mice Models Industry

Key Drivers: The increasing prevalence of chronic diseases, coupled with the rising demand for effective treatments, drives the growth of the mice models market. Advances in gene editing technologies, such as CRISPR-Cas9, allow for the creation of highly specific and customized models for research purposes, enhancing the market's growth. The expanding pharmaceutical and biotechnology industry, along with increased research funding, contributes significantly to this growth.

Key Barriers and Challenges: Stringent regulatory requirements for animal research pose a significant challenge to market expansion. The high cost associated with developing and maintaining genetically modified mice models can limit accessibility for smaller research organizations. Competition from alternative research methodologies such as in silico modeling also presents a challenge. Estimated regulatory hurdles add xx million USD in extra costs per annum. Supply chain disruptions can also impact the availability and cost of mice models.

Emerging Opportunities in Mice Models Industry

Emerging opportunities include the development of humanized mouse models, which more closely mimic human physiology, allowing for better translation of research findings to humans. There is growing interest in developing models for personalized medicine, enabling researchers to study individual patient responses to disease and treatments. The development of novel mouse models for orphan diseases or rare conditions offers substantial market potential. Expanding applications in areas such as immunology and regenerative medicine provide additional growth avenues.

Growth Accelerators in the Mice Models Industry

Technological advancements in gene editing, particularly CRISPR-Cas9 technology, are primary drivers of long-term growth. Strategic partnerships between research institutions, pharmaceutical companies, and model providers enhance market expansion. The expanding application of mice models to investigate various disease mechanisms and treatment strategies supports sustained growth. Increased investment in research and development, particularly in the field of personalized medicine, strengthens market potential.

Key Players Shaping the Mice Models Industry Market

• Ozgene Pty Ltd
• The Jackson Laboratory
• Janvier Labs
• The Andersons Inc
• Trans Genic Inc
• Ingenious Targeting Laboratory
• ENVIGO
• Charles River Laboratories International Inc
• Taconic Biosciences Inc
• Genoway
• Horizon Discovery Group PLC (Sage Labs Inc)
• Allentown LLC
• Harbour Biomed
• PolyGene

Notable Milestones in Mice Models Industry Sector

• November 2023: Scientists at the UCI MODEL-AD group developed the Trem2R47H NSS mouse model for Alzheimer's disease research.
• February 2024: University of Texas Southwestern Medical Center introduced a new compound extending survival in an ALS mouse model.

In-Depth Mice Models Industry Market Outlook

The mice models market is poised for sustained growth over the forecast period, driven by technological advancements, expanding research activities, and increasing demand for precise disease models. Strategic partnerships and collaborations within the industry are expected to further accelerate market expansion. The emergence of novel applications and the development of more sophisticated mouse models will continue to shape market dynamics. The market's future potential lies in the application of advanced technologies, personalized medicine research, and the investigation of complex diseases, promising significant growth opportunities for industry stakeholders.

Mice Models Industry Segmentation

• 1. Type
  • 1.1. Inbred Mice
  • 1.2. Outbred Mice
  • 1.3. Genetically Engineered Mice
  • 1.4. Hybrid/Congenic Mice
  • 1.5. Other Types
• 2. Service
  • 2.1. Breeding
  • 2.2. Cryopreservation
  • 2.3. Model in-Licensing
  • 2.4. Genetic Testing
  • 2.5. Other Services
• 3. Technology
  • 3.1. CRISPR/CAS9
  • 3.2. Embryonic Stem Cell Injection
  • 3.3. Nuclear Transfer
  • 3.4. Other Technologies
• 4. Application
  • 4.1. Oncology
  • 4.2. Cardiovascular Studies
  • 4.3. Neurology
  • 4.4. Other Applications

Mice Models Industry Segmentation By Geography

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. Europe
  • 2.1. Germany
  • 2.2. United Kingdom
  • 2.3. France
  • 2.4. Italy
  • 2.5. Spain
  • 2.6. Rest of Europe
• 3. Asia Pacific
  • 3.1. China
  • 3.2. Japan
  • 3.3. India
  • 3.4. Australia
  • 3.5. South Korea
  • 3.6. Rest of Asia Pacific
• 4. Middle East and Africa
  • 4.1. GCC
  • 4.2. South Africa
  • 4.3. Rest of Middle East and Africa
• 5. South America
  • 5.1. Brazil
  • 5.2. Argentina
  • 5.3. Rest of South America